This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_TONGUE_EXALLC for full statistics.
Malignant neoplasm of tongue
C3_TONGUE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
661 |
6. Filter based on genotype QC (FinnGen only) |
661 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of tongue
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oral cavity
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 661 | 257 | 404 |
| Unadjusted period prevalence (%) | 0.14 | 0.09 | 0.18 |
| Median age at first event (years) | 63.47 | 61.99 | 64.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 620
- Matched controls
- 6201
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
162.6
323.0
353
50
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
5353.0
323.0
394
*
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
243.2
217
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
430.7
235.3
222
8
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
127.0
228.8
237
30
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
2720.3
200.3
183
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
127.8
198.2
206
24
130
Kela drug reimbursment
Malignant tumour
17.5
173.4
305
325
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
+∞
159.4
146
*
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
157.1
144
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
204.0
141.2
142
9
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
140.0
129
*
GBB00
NOMESCO Finland
Tracheostomy
66.3
135.5
155
31
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
61.5
119.9
139
29
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
153.0
119.0
123
10
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
64.3
107.7
124
24
EP1AE
NOMESCO Finland
Neck ultrasound examination
16.4
107.5
183
154
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.8
90.7
390
1396
SAA03
NOMESCO Finland
Extended examination of mouth
5.6
86.7
397
1499
N02AA05
ATC
oxycodone; systemic
6.8
83.6
255
579
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
914.5
83.5
80
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
94.4
81.5
89
11
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
121.2
79.1
84
8
WF003
NOMESCO Finland
Adjuvant radiotherapy
16.0
75.9
128
99
UJC01
NOMESCO Finland
Scopy of lower throat
38.8
73.4
93
28
A07AA02
ATC
nystatin; oral
10.6
73.1
152
184
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
16.3
70.8
118
88
WF002
NOMESCO Finland
Radical radiotherapy
10.0
69.4
149
190
K13.29
ICD-10 Finland
Indefinite leukoplakia
38.7
68.6
87
26
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
64.8
314
1135
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
19.7
64.8
100
60
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
+∞
64.7
61
*
R4190
NOMESCO Finland
Nutritional therapy
16.8
64.6
106
75
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
+∞
63.6
60
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
72.6
62.8
71
11
EBA15
NOMESCO Finland
Extraction of large number of teeth
11.4
62.8
124
133
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
43.7
62.4
77
20
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
50.7
60.1
72
16
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.2
59.8
183
391
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
10.0
58.9
125
153
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
13.1
56.9
104
94
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
10.3
56.9
118
138
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
575.8
54.4
53
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.3
54.0
129
191
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
54.0
241
771
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.8
53.0
364
1697
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
72.2
52.2
59
9
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.1
50.3
105
123
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
+∞
49.7
47
*
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
+∞
47.5
45
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
45.4
43
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
61.5
44.1
51
9
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
86.6
43.5
48
6
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
+∞
41.1
39
*
SXA10
NOMESCO Finland
Epithel biopsy of mouth
25.0
40.5
57
25
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
34.6
39.5
51
16
K13.78
ICD-10 Finland
Other change in the oral mucosa
14.8
37.1
63
47
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
134.7
36.1
38
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.2
34.4
146
419
WX402
NOMESCO Finland
General anaesthesia
3.6
34.4
182
634
K13.20
ICD-10 Finland
Idiopathic leukoplakia
80.9
34.2
38
5
EBA10
NOMESCO Finland
Surgical removal of tooth
4.6
33.7
129
334
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
179.5
33.0
34
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
42.7
32.5
40
10
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
8.9
32.3
71
89
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.2
32.0
91
167
ZX095
NOMESCO Finland
Combined chemoradiotherapy
24.8
31.4
44
19
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
24.8
31.4
44
19
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
328.6
31.1
31
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
23.6
30.9
44
20
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
43.6
30.3
37
9
ENA10
NOMESCO Finland
Biopsy of pharynx
52.8
29.7
35
7
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.9
28.8
56
56
SBB10
NOMESCO Finland
Teeth copy
5.8
28.7
85
164
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.8
28.4
85
166
SAA04
NOMESCO Finland
Special inverstigation of mouth
6.2
28.1
79
142
SXC03
NOMESCO Finland
Other oral or dental procedure
18.4
27.9
43
25
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
5.5
27.7
86
175
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
56.1
27.4
32
6
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
56.1
27.4
32
6
ZX090
NOMESCO Finland
Other technic of radiotherapy
7.8
27.1
64
90
WX110
NOMESCO Finland
Local anesthesy
2.7
26.9
466
3276
EBB15
NOMESCO Finland
Insertion of dental implant abutment
21.8
26.8
39
19
R13
ICD-10 Finland
Dysphagia
5.0
26.8
91
205
EBB10
NOMESCO Finland
Insertion of dental implant
13.3
26.3
46
37
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
26.2
167
652
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.8
26.1
92
216
TJD20
NOMESCO Finland
Change of gastrostomy tube
75.7
26.0
29
*
A04AA02
ATC
granisetron; systemic, transdermal
5.1
26.0
87
193
ECA20
NOMESCO Finland
Biopsy of gingiva
24.6
25.1
35
15
WZC30
NOMESCO Finland
Teaching
3.3
25.0
142
508
D10.12
ICD-10 Finland
Bone tumor of the tip of the tongue
260.0
24.9
25
*
K14.9
ICD-10 Finland
Disease of tongue, unspecified
44.9
24.8
30
7
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
28.9
24.7
33
12
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.3
23.9
95
251
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
90.4
23.8
26
*
T05
ICPC
Feeding problem of adult
43.4
23.8
29
7
EDB00
NOMESCO Finland
Partial excision of mandible
43.4
23.8
29
7
SBA00
NOMESCO Finland
Microbiological examinations
9.7
23.5
48
53
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.5
23.4
46
47
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
23.2
84
202
PJA12
NOMESCO Finland
Sentinel node biopsy
4.7
23.1
83
198
SAA02
NOMESCO Finland
Basic examination of mouth
2.4
23.0
402
2710
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
67.7
23.0
26
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.5
23.0
51
65
EKA10
NOMESCO Finland
Biopsy of cheek
8.9
22.8
49
59
H02AB02
ATC
dexamethasone; systemic
3.6
22.3
112
362
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
22.2
333
2068
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
22.0
21
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
32.5
21.7
28
9
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.3
21.2
67
139
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
3.9
20.8
90
256
D20
ICPC
Mouth/tongue/lip symptom/complaint
5.9
20.2
58
107
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
5.1
20.1
65
138
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
7.1
20.1
50
76
R4110
NOMESCO Finland
Physiotherapy
2.4
19.9
211
1088
8070/3-C02.2
ICD-O-3
Squamous cell carcinoma, NOS, of ventral surface of tongue, NOS
+∞
19.9
19
*
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
+∞
19.9
19
*
ZXC10
NOMESCO Finland
Use of laser
7.8
19.8
46
63
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
206.3
19.7
20
*
ZZA00
NOMESCO Finland
Split skin graft
6.6
19.5
51
83
R4130
NOMESCO Finland
Speech therapy
8.3
19.4
43
55
J02AC01
ATC
fluconazole; systemic
2.3
19.2
241
1345
EBA00
NOMESCO Finland
Extraction of tooth
2.3
19.1
237
1316
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
12.3
19.0
34
29
A04AA01
ATC
ondansetron; systemic, rectal
4.1
18.9
77
207
C02.4
ICD-10 Finland
Malignant neoplasm: Lingual tonsil
+∞
18.8
18
*
K11.70
ICD-10 Finland
Hypoptyalism
21.6
18.8
27
13
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
12.4
18.5
33
28
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
9.3
18.4
38
43
A06AD11
ATC
lactulose; oral
2.8
18.0
134
563
Z51.5
ICD-10 Finland
Palliative care
4.0
18.0
75
206
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.0
17.8
75
208
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.3
17.7
201
1059
A01AB09
ATC
miconazole; local oral
3.5
17.7
88
280
4392
FHL
Tongue and / or Mouth resection or excision
97.9
17.6
19
*
WX002
NOMESCO Finland
Sedation and analgesia
2.5
17.5
165
792
K05.31
ICD-10 Finland
Periodontitis pronounced
3.1
17.5
102
365
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
51.5
17.1
20
*
K14.61
ICD-10 Finland
Glossodynia
20.0
17.0
25
13
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
16.9
191
1001
K05.30
ICD-10 Finland
Periodontitis complex
2.9
16.9
111
430
WX707
NOMESCO Finland
Fiberoscopic intubation
65.2
16.8
19
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
28.4
16.6
22
8
A04AD12
ATC
aprepitant; systemic
7.4
16.4
39
56
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
15.9
16.3
26
17
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
10.5
16.1
31
31
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.2
16.0
63
164
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
61.7
15.8
18
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
15.7
123
529
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.7
15.5
53
120
ZXE00
NOMESCO Finland
One hour or less
2.0
15.5
270
1699
K08.3
ICD-10 Finland
Retained dental root
3.5
15.4
74
229
SXC05
NOMESCO Finland
Other oral or dental procedure
4.3
15.3
57
141
ECB20
NOMESCO Finland
Oral alveoplasty
14.4
15.1
25
18
D83
ICPC
Mouth/tongue/lip disease
32.6
14.9
19
6
K02.1
ICD-10 Finland
Caries of dentine
2.0
14.7
344
2409
4707
FHL
Dissection Colli radicalis
+∞
14.6
14
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
82.1
14.6
16
*
1412A
ICD-9 Finland
Malignant neoplasm of tongue, Tip and lateral border of tongue
153.4
14.5
15
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
10.1
14.3
28
29
B37.08
ICD-10 Finland
Other candidal stomatitis
13.8
14.3
24
18
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
14.1
252
1583
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.5
14.0
68
212
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
54.6
13.9
16
*
Z3226
NOMESCO Finland
Physiotherapist
2.3
13.8
140
685
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.3
13.5
41
82
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
26.4
13.4
18
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
13.1
144
732
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
13.1
100
422
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
13.4
13.0
22
17
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
13.4
13.0
22
17
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
19.5
13.0
19
10
SDA02
NOMESCO Finland
Parodonthologic therapy
2.0
12.9
200
1182
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
9.3
12.8
26
29
C04.9
ICD-10 Finland
Malignant neoplasm: Floor of mouth, unspecified
71.3
12.6
14
*
EJB50
NOMESCO Finland
Total glossectomy
+∞
12.5
12
*
C02.3
ICD-10 Finland
Malignant neoplasm: Anterior two-thirds of tongue, part unspecified
+∞
12.5
12
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
132.6
12.5
13
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
132.6
12.5
13
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
12.5
253
1649
SPF30
NOMESCO Finland
Soling for prothesis
6.2
12.4
33
56
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
12.1
410
3170
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.9
11.8
23
24
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
6.0
11.8
32
56
EKB00
NOMESCO Finland
Excision of lesion of cheek
19.4
11.6
17
9
K12.10
ICD-10 Finland
Stomatitis NOS
19.4
11.6
17
9
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
10.3
11.6
22
22
EJC30
NOMESCO Finland
Reconstruction of tongue
+∞
11.5
11
*
EJB70
NOMESCO Finland
Extensive partial excision of floor of mouth and tongue
+∞
11.5
11
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
122.2
11.5
12
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
35.7
11.3
14
*
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
17.4
11.2
17
10
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
17.4
11.2
17
10
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.8
11.1
27
41
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.5
11.1
39
92
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
44.1
11.0
13
*
WW500
NOMESCO Finland
Blood transfusion
4.1
10.9
42
108
WF004
NOMESCO Finland
Palliative radiotherapy
5.8
10.9
30
54
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
21.9
10.7
15
7
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
13.2
10.7
18
14
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
10.7
52
163
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.9
10.7
29
51
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
10.7
219
1414
A01AB04
ATC
amphotericin B; local oral
3.7
10.7
46
131
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
10.6
72
282
ZXA05
NOMESCO Finland
Left side
1.9
10.5
175
1049
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
10.4
10
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.5
10.4
49
150
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
19.2
10.3
15
8
Z2446
NOMESCO Finland
Social worker
3.1
10.2
55
186
H03AA01
ATC
levothyroxine sodium; systemic
2.0
10.0
145
822
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.8
9.9
41
113
ECA30
NOMESCO Finland
Excision of lesion of gingiva
8.0
9.7
21
27
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
9.6
67
268
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
6.8
9.5
23
35
Z50.5
ICD-10 Finland
Speech therapy
7.7
9.5
21
28
L43.8
ICD-10 Finland
Other lichen planus
5.7
9.4
26
47
K10.21
ICD-10 Finland
Osteoradionecrosis of jaw (acute)(chronic)(suppurative)
101.5
9.4
10
*
EJB60
NOMESCO Finland
Partial excision of floor of mouth
101.5
9.4
10
*
SPF20
NOMESCO Finland
Temporary soling for filling
8.2
9.4
20
25
ZXE90
NOMESCO Finland
More than 22 hours
12.6
9.4
16
13
8085/3-C01.9
ICD-O-3
Squamous cell carcinoma, HPV positive of base of tongue, NOS
+∞
9.4
9
*
QA7S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in jaw or lips
+∞
9.4
9
*
1410A
ICD-9 Finland
Malignant neoplasm of tongue, Base of tongue
+∞
9.4
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
9.3
190
1213
SCA03
NOMESCO Finland
Preventive oral health care, extensive
3.8
9.3
38
104
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.9
9.2
151
894
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
9.1
60
229
N02BE01
ATC
paracetamol; systemic, rectal
1.9
9.1
521
4534
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
10.2
9.1
17
17
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
37.3
9.0
11
*
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.5
9.0
31
72
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
24.4
8.9
12
5
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
8.9
69
292
EMB10
NOMESCO Finland
Tonsillectomy
3.8
8.9
36
98
UDQ22
NOMESCO Finland
Microlaryngoscopy
10.9
8.8
16
15
UJC02
NOMESCO Finland
Rigid oesophagoscopy
9.7
8.8
17
18
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
50.7
8.7
10
*
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
50.7
8.7
10
*
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
9.2
8.6
17
19
EB1WA
NOMESCO Finland
NA
9.2
8.6
17
19
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
8.5
50
180
K10.25
ICD-10 Finland
Sequences of jawbones
27.9
8.5
11
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
91.2
8.4
9
*
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
+∞
8.3
8
*
4394
FHL
Glossectomy or hemiglossectomy
+∞
8.3
8
*
EHA10
NOMESCO Finland
Biopsy of palate
14.7
8.2
13
9
GBB13
NOMESCO Finland
Revision of tracheostomy
33.8
8.1
10
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.1
8.1
30
76
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.3
8.0
72
330
Z2221
NOMESCO Finland
Medical doctor
1.8
8.0
170
1089
RD210
NOMESCO Finland
NA
6.7
7.9
19
29
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
3.1
7.9
42
143
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
7.8
35
104
S01.50
ICD-10 Finland
Open wound in oral cavity
9.6
7.8
15
16
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
3.3
7.7
38
122
D77
ICPC
Malignant digestive neopl other/NOS
13.6
7.4
12
9
8071/3-C02.1
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of border of tongue
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
6.4
7.3
18
29
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.5
7.2
56
237
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
16.0
7.2
11
7
R07.0
ICD-10 Finland
Pain in throat
3.0
7.2
41
144
L43.9
ICD-10 Finland
Lichen planus, unspecified
4.5
7.2
24
55
EJ2S1
NOMESCO Finland
Photography of oral mucosa
30.4
7.2
9
*
K14.88
ICD-10 Finland
Other diseases of tongue
30.4
7.2
9
*
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
20.3
7.1
10
5
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
20.3
7.1
10
5
J01DB01
ATC
cefalexin; oral
1.7
7.1
484
4201
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
12.2
7.1
12
10
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
4.8
7.1
22
47
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
10.2
7.1
13
13
A04AA55
ATC
palonosetron, combinations; systemic
3.9
7.0
27
71
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.0
136
845
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.0
154
996
K14.69
ICD-10 Finland
Tongue pain UNS
14.0
6.9
11
8
XQ902
NOMESCO Finland
Other photography
9.5
6.8
13
14
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
40.5
6.8
8
*
EEB00
NOMESCO Finland
Partial excision of maxilla
40.5
6.8
8
*
SPA02
NOMESCO Finland
Preparation for dental prosthetics
4.2
6.8
24
59
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.4
6.7
54
235
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
6.7
41
153
EWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of teeth, jaws, mouth and pharynx
22.8
6.7
9
*
K14.09
ICD-10 Finland
Glossit UNS
22.8
6.7
9
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
22.8
6.7
9
*
SCB02
NOMESCO Finland
Training for mouth care at home
22.8
6.7
9
*
R02AD02
ATC
lidocaine; local oral
5.3
6.7
19
37
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.1
6.7
24
60
WX199
NOMESCO Finland
Other local analgesia
4.1
6.7
24
60
UJC12
NOMESCO Finland
Flexible oesophagoscopy
7.9
6.6
14
18
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.6
264
1990
K03.66
ICD-10 Finland
Tooth plaque
2.7
6.6
43
167
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.6
185
1278
K02.2
ICD-10 Finland
Caries of cementum
3.1
6.5
33
109
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
4.3
6.5
22
52
A01AB10
ATC
natamycin; local oral
3.8
6.4
25
67
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
70.5
6.4
7
*
SPA05
NOMESCO Finland
Guiding rail
70.5
6.4
7
*
RS316
NOMESCO Finland
NA
14.5
6.4
10
7
JDB00
NOMESCO Finland
Gastrostomy
14.5
6.4
10
7
ZXB10
NOMESCO Finland
Medial
8.3
6.4
13
16
JN6AD
NOMESCO Finland
CT of torso and neck
5.6
6.3
17
31
TEA00
NOMESCO Finland
Biopsy of lip
9.4
6.3
12
13
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
18.2
6.3
9
5
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
18.2
6.3
9
5
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
6.3
6
*
C02
ICD-10 Finland
Malignant neoplasm of other and unspecified parts of tongue
+∞
6.3
6
*
SPC45
NOMESCO Finland
Preparation of third or later intermediate attachment tooth for bridge
+∞
6.3
6
*
GBB18
NOMESCO Finland
Closure of tracheostomy
+∞
6.3
6
*
ENB20
NOMESCO Finland
Pharyngectomy
+∞
6.3
6
*
QA9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head or neck, unspecified
+∞
6.3
6
*
Z92.3
ICD-10 Finland
Personal history of irradiation
+∞
6.3
6
*
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
+∞
6.3
6
*
C10.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oropharynx
+∞
6.3
6
*
C06.9
ICD-10 Finland
Malignant neoplasm: Mouth, unspecified
+∞
6.3
6
*
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
7.1
6.2
14
20
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.0
6.2
23
59
EDA10
NOMESCO Finland
Biopsy of mandible
27.0
6.2
8
*
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
27.0
6.2
8
*
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
3.8
6.1
24
65
K12.18
ICD-10 Finland
Other forms of stomatitis
8.7
6.1
12
14
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.7
6.0
24
66
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.7
6.0
24
66
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
291
574
8.27
156.28
2.4
2.3
g/l
0.2
0.2
4.38
279
536
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
92
22
48.42
155.67
3.9
2.4
—
—
—
0
0
(4035726)
252
503
7.48
131.34
1.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
296
943
4.87
86.88
6.2
3.6
mmol/l
0.8
0.8
12.36
284
889
(40768804) Tissue Pathology biopsy report
458
2096
4.86
81.89
3.8
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
104
130
9.31
79.82
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
65
63
11.33
59.71
1.8
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
299
1350
3.22
46.76
2.8
2.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
207
760
3.51
45.33
6.2
6.3
mmol/l
1.0
1.0
3.02
202
701
(3015377) Calcium [Moles/volume] in Serum or Plasma
357
1832
3.06
43.85
4.9
3.5
mmol/l
2.4
2.4
3.12
334
1608
(3044640) Blood type and Crossmatch panel - Blood
349
1774
3.05
43.51
3.1
2.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
423
2456
3.01
40.28
5.2
5.1
g/l
35.1
35.3
0.26
400
2305
(3020779) Urea [Moles/volume] in Serum or Plasma
160
535
3.63
40.01
5.5
7.9
mmol/l
5.8
10.0
18.08
155
508
(3002256) Pathology report gross observation
184
678
3.37
39.45
1.4
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
432
2561
2.98
39.14
4.3
4.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
274
1404
2.63
30.95
5.4
4.1
%
87.3
88.5
0.33
269
1373
(3032080) INR in Blood by Coagulation assay
394
2419
2.56
30.08
6.4
9.7
inr
1.1
1.3
6.57
105
682
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
156
629
2.94
27.71
1.6
1.8
%
1.9
1.5
2.37
137
541
(3013650) Neutrophils [#/volume] in Blood by Automated count
459
3130
2.53
26.41
11.1
9.3
e9/l
4.1
4.2
0.35
417
2752
(3007853) Bacteria identified in Skin by Aerobe culture
155
658
2.77
24.75
1.9
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
435
2989
2.33
23.13
7.9
6.7
umol/l
10.1
11.8
4.67
416
2839
(3013826) Glucose [Moles/volume] in Serum or Plasma
462
3323
2.30
21.04
7.1
5.1
mmol/l
6.6
6.8
2.41
453
3126
(3000494) Fungus identified in Specimen by Culture
151
687
2.55
20.65
1.8
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
378
2543
2.14
19.92
7.4
6.4
mmol/l
1.2
1.2
1.69
355
2294
(40758558) Short blood count panel - Blood
238
1346
2.20
19.61
9.2
6.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
273
1634
2.14
19.42
4.9
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
245
1417
2.16
18.94
1.6
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
388
2772
1.97
15.79
8.1
7.3
mmol/l
1.2
1.2
1.40
328
2337
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
528
4247
2.21
15.00
9.9
8.0
u/l
78.9
79.0
0.02
517
3992
(3018418) pH of Serum or Plasma
261
1652
1.96
14.98
4.5
4.4
ph
7.4
7.4
0.04
53
317
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
82
323
2.76
14.72
9.3
10.1
mmol/l
24.9
24.6
0.59
75
305
(3006315) Basophils [#/volume] in Blood
375
2697
1.90
14.43
5.8
5.8
e9/l
0.0
0.0
0.41
318
2340
(3001604) Monocytes [#/volume] in Blood
372
2684
1.88
14.01
5.8
5.7
e9/l
0.6
0.6
0.32
315
2317
(3013115) Eosinophils [#/volume] in Blood
381
2779
1.88
13.77
6.0
5.9
e9/l
0.2
0.2
0.10
330
2445
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
136
698
2.19
13.66
8.3
7.8
kpa
5.4
5.1
3.67
127
671
(3006504) Eosinophils/100 leukocytes in Blood
355
2537
1.86
13.64
6.1
5.9
%
2.8
2.9
0.40
335
2369
(3027801) Oxygen [Partial pressure] in Arterial blood
136
699
2.19
13.61
8.3
7.8
kpa
13.2
12.1
1.60
129
675
(3022096) Basophils/100 leukocytes in Blood
347
2471
1.85
13.40
6.2
5.9
%
0.6
0.7
0.47
326
2310
(3019069) Monocytes/100 leukocytes in Blood
355
2549
1.85
13.32
6.3
6.2
%
9.0
8.9
0.25
335
2391
(42870588) Differential panel, method unspecified - Blood
274
1819
1.86
13.19
6.0
5.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
374
2737
1.84
13.12
5.8
5.8
e9/l
1.8
1.9
0.17
322
2412
(3003396) Base excess in Arterial blood by calculation
134
696
2.16
13.02
8.3
7.9
mmol/l
1.5
1.2
0.37
108
543
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
130
668
2.18
12.97
2.3
2.9
umol/l
10.4
8.9
0.19
117
603
(3002030) Lymphocytes/100 leukocytes in Blood
357
2595
1.82
12.61
6.2
6.1
%
23.3
27.1
6.69
337
2416
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
98
455
2.35
12.44
3.4
2.9
ml/min/173m2
67.8
64.4
0.32
39
183
(3018010) Neutrophils/100 leukocytes in Blood
351
2548
1.81
12.36
5.9
5.8
%
60.8
57.6
4.13
330
2392
(3042936) Bacteria identified in Isolate by Culture
154
865
2.02
12.07
2.0
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
112
602
2.04
9.77
4.0
3.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
318
2355
1.68
9.54
13.5
10.1
e9/l
0.0
0.0
0.60
251
1951
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
37
5.26
9.41
1.0
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
255
1791
1.69
9.29
2.7
3.5
u/l
37.3
33.3
0.56
245
1702
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
471
3902
1.72
8.92
4.7
3.7
pmol/l
14.6
14.9
2.19
432
3493
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
432
3498
1.68
8.91
3.4
3.3
u/l
63.0
54.9
0.95
403
3257
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
165
1041
1.78
8.75
4.8
3.2
mmol/l
2.5
2.5
3.46
149
923
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
596
5338
2.18
8.44
25.1
15.6
mg/l
31.2
25.9
3.83
540
4274
(3014576) Chloride [Moles/volume] in Serum or Plasma
131
781
1.84
8.34
7.1
7.0
mmol/l
104.1
104.0
0.06
131
761
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
152
951
1.78
8.24
1.8
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
59
4.00
8.21
1.4
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
92
494
2.00
8.00
9.7
9.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
326
2.21
7.94
1.5
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
97
537
1.95
7.72
8.6
7.3
mmol/l
1.2
1.4
1.40
89
516
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
17
36
4.82
7.67
1.4
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
30
97
3.19
7.65
1.7
1.3
mmol/l
64.5
62.1
0.08
22
86
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
56
3.84
7.13
1.0
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
277
2100
1.55
6.83
2.3
2.2
nmol/l
75.9
77.0
0.21
251
1858
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
70
372
1.99
6.25
1.8
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
479
5322
0.64
5.93
4.2
4.6
mmol/l
1.5
1.4
1.79
432
4871
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
84
484
1.84
5.89
1.7
3.0
ng/l
261.4
217.2
0.26
77
438
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
284
2.06
5.69
1.1
1.2
iu/ml
148.8
144.3
0.03
19
108
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
74
418
1.87
5.53
1.7
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
486
5358
0.65
5.37
4.2
4.7
mmol/l
4.5
4.6
0.53
439
4933
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
87
2.82
5.09
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
558
5079
1.63
4.97
23.7
14.5
ml/min/173m2
83.3
78.5
7.12
506
4228
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
134
927
1.56
4.73
3.0
3.1
e6/l
2.3
1.6
0.42
76
532
(3002582) Erythrocytes [#/volume] in Urine
224
1735
1.44
4.53
3.4
3.3
e6/l
101.1
92.4
0.04
177
1358
(3051651) Icteric interference index of Serum or Plasma
15
44
3.47
4.49
3.3
4.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
82
509
1.70
4.47
4.6
2.2
nmol/l
424.9
371.5
1.35
77
467
(3030467) Casts [#/volume] in Urine by Automated count
207
1588
1.44
4.38
3.3
3.2
e6/l
0.5
0.5
0.02
163
1207
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
529
4796
1.52
4.37
5.6
4.5
mu/l
2.7
2.2
0.93
492
4327
(3013707) Erythrocyte sedimentation rate by Westergren method
453
3987
1.43
4.36
3.6
4.1
mm/h
14.5
12.8
1.51
425
3669
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
503
5458
0.67
4.34
4.6
5.2
mmol/l
2.6
2.7
1.60
454
5000
(3044889) 12 lead EKG panel
448
3938
1.43
4.32
4.1
4.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
206
2.06
4.32
1.8
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
114
776
1.57
4.30
17.9
23.7
inr
1.3
1.3
0.09
15
97
(3026782) Osmolality of Urine
154
1123
1.48
4.22
2.9
2.9
mosm/kgh2o
517.2
568.3
2.26
132
963
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.17
1.6
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.17
1.6
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
140
1883
0.67
4.11
2.8
3.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
197
1515
1.43
4.07
3.3
3.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
225
1.97
4.06
1.9
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
42
3.38
4.06
1.9
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
182
1380
1.44
4.06
2.3
2.1
mg/l
2.6
3.1
3.09
160
1181
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
149
1097
1.46
3.86
4.2
4.1
ng/l
280.7
311.4
0.08
128
912
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
471
5146
0.71
3.85
3.9
4.2
mmol/l
1.3
1.3
0.61
429
4691
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
678
1.56
3.83
1.8
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
118
832
1.51
3.79
2.6
2.5
g/l
2.2
2.3
1.01
108
775
(3019060) Gas panel - Arterial blood
65
399
1.70
3.71
5.4
4.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
96
652
1.55
3.65
1.2
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
596
5603
1.65
3.63
28.0
18.3
mmol/l
138.6
139.7
16.20
589
5458
(3018095) Leukocytes [#/volume] in Urine
243
1969
1.37
3.62
4.0
3.8
e6/l
52.0
90.3
0.88
185
1443
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
99
681
1.53
3.56
1.9
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
165
2.05
3.55
4.1
3.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
39
208
1.93
3.52
3.0
3.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
63
2.74
3.51
3.3
3.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
81
534
1.59
3.51
3.0
2.4
u/l
33.5
35.7
0.13
70
457
(3019309) Folate [Moles/volume] in Red Blood Cells
142
1058
1.44
3.43
1.9
1.7
nmol/l
1113.0
1196.9
0.51
100
800
(3023199) Leukocytes [#/volume] in Pleural fluid
17
64
2.70
3.42
1.4
1.3
e6/l
751.9
1610.6
—
9
43
(3022948) Iron [Moles/volume] in Serum or Plasma
125
910
1.46
3.41
2.6
2.5
umol/l
11.6
13.0
1.16
118
845
(3023103) Potassium [Moles/volume] in Serum or Plasma
596
5622
1.61
3.34
28.0
18.5
mmol/l
4.0
4.0
4.61
587
5473
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
111
795
1.48
3.29
2.7
2.5
%
21.9
23.0
0.28
97
685
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
43
3.06
3.26
1.2
1.5
promille
1.5
1.2
—
8
36
(40761511) CBC panel - Blood by Automated count
589
5547
1.57
3.25
21.2
14.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
33
3.37
3.20
1.6
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
156
1197
1.40
3.18
2.6
2.6
e6/l
7.2
4.4
0.91
135
1061
(3020682) Albumin/Creatinine [Ratio] in Urine
145
1865
0.71
3.16
4.0
4.0
mg/mmol
8.8
9.3
0.07
87
1202
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
163
2055
0.73
3.14
3.4
3.9
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
30
154
1.99
3.04
1.8
3.2
umol/l
34.7
33.5
0.06
22
127
(3021960) Folate [Moles/volume] in Serum or Plasma
174
1370
1.37
3.02
1.5
1.5
nmol/l
20.6
20.4
0.07
147
1146
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
53
329
1.66
2.94
8.8
10.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
109
2.15
2.87
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
109
2.15
2.87
1.5
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
12
41
2.96
2.87
1.6
1.5
u/l
43.3
33.1
0.34
12
33
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
269
1.72
2.86
1.5
2.1
g/l
1.7
1.5
0.48
39
234
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
59
2.58
2.80
1.5
1.3
e6/l
18080.0
158455.3
—
6
33
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
129
980
1.39
2.77
2.8
2.9
e6/l
0.9
1.0
0.27
73
578
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.38
2.75
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
6
8.38
2.75
1.0
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
139
1762
0.73
2.70
3.2
3.3
mg/l
65.8
337.6
2.14
86
1162
(4010399)
62
410
1.57
2.68
1.3
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
170
1.86
2.63
1.6
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
216
1788
1.31
2.63
2.5
3.1
ng/l
1243.4
1362.4
0.13
194
1523
(3009508) Creatinine [Moles/volume] in Urine
146
1821
0.75
2.52
3.1
3.1
mmol/l
6.8
7.9
1.75
116
1515
(3027945) Reticulocytes/100 erythrocytes in Blood
95
697
1.42
2.49
2.0
2.7
%
1.8
1.8
0.07
82
628
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
103
2.07
2.44
1.7
3.1
e9/l
4.3
4.4
0.10
21
103
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
64
0.00
2.43
0.0
1.2
—
7.9
—
0
45
(3012501) Base excess in Blood by calculation
23
118
1.98
2.38
4.5
4.5
mmol/l
3.1
2.5
0.94
16
79
(3045788) Cell count panel - Pleural fluid
13
52
2.53
2.37
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
65
2.34
2.33
1.8
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
106
2.01
2.28
1.8
3.6
%
64.9
58.2
1.39
21
106
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
13
4.65
2.27
1.3
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
471
4352
1.29
2.25
30.3
19.1
%
13.9
13.8
0.95
464
4266
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
119
1506
0.74
2.24
1.5
1.7
mmol/l
1.3
1.4
1.70
99
1263
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
242
2068
1.27
2.24
3.4
3.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
60
2.36
2.23
1.4
1.4
—
—
—
0
0
(3020891) Body temperature
38
234
1.66
2.22
6.7
4.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
250
2158
1.25
2.10
2.8
2.7
ug/l
166.2
154.6
0.30
233
1978
(3019230) Fractional oxyhemoglobin in Venous blood
20
103
1.97
2.07
1.3
2.2
%
56.8
62.4
0.47
20
103
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
804
0.68
2.06
1.2
1.3
u/ml
10.0
14.1
0.27
25
316
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
327
2913
1.24
2.06
2.3
2.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
15
4.03
2.04
1.0
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
15
4.03
2.04
1.3
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
16
76
2.13
2.04
1.4
1.5
g/l
34.2
31.6
0.31
11
65
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
201
1.68
2.02
2.8
2.7
u/ml
0.3
0.3
0.04
20
112
(3019150) Specific gravity of Urine by Refractometry
90
1165
0.74
1.96
3.3
4.0
kg/l
1.0
1.0
—
7
154
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
852
0.70
1.95
1.3
1.3
iu/ml
29.2
37.4
0.29
16
271
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
209
1783
1.25
1.91
3.3
2.6
u/l
50.1
58.0
2.59
198
1659
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
594
5706
1.40
1.90
13.3
11.0
u/l
25.5
27.3
2.04
579
5499
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
144
1.77
1.87
1.3
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
46
2.41
1.86
1.1
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
36
544
0.64
1.84
1.5
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
202
1726
1.25
1.81
2.2
2.1
u/l
171.8
229.9
1.19
190
1626
(40768795) Lymph node Pathology biopsy report
12
53
2.29
1.81
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
23
3.06
1.80
2.4
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
102
1.89
1.78
1.7
1.8
—
—
—
0
0
(3019225) pH of Specimen
73
545
1.38
1.77
3.9
4.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
67
2.11
1.77
1.4
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
24
2.94
1.72
2.4
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
84
1.93
1.61
1.8
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
57
2.13
1.56
4.6
3.6
%
57.4
55.8
—
7
41
(3025130) Human papilloma virus identified in Specimen
8
33
2.44
1.54
1.5
2.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
33
2.44
1.54
1.8
1.6
g/l
1.1
1.0
—
8
33
(40767503) Oxygen content in Capillary blood by calculation
20
115
1.76
1.54
2.8
2.7
%
14.4
16.0
—
6
62
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
42
0.00
1.53
0.0
2.4
—
151.2
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
27
2.61
1.52
1.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
45
0.00
1.50
0.0
1.1
—
0.1
—
0
6
(3035350) Ketones [Presence] in Urine by Test strip
233
2611
0.83
1.44
3.3
3.7
estimate
0.0
0.0
0.00
58
497
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
16
3.14
1.44
2.0
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
234
2616
0.84
1.40
4.3
5.0
estimate
0.0
0.0
0.00
59
498
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
29
2.43
1.39
2.7
2.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
29
2.43
1.39
1.3
2.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
19
307
0.61
1.34
1.3
1.3
—
35.6
—
0
20
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
180
2054
0.83
1.34
3.7
4.2
%
20.5
21.1
0.20
78
993
(3041096) Erythrocytes [Presence] in Urine by Automated
122
1446
0.81
1.33
3.2
3.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
238
2645
0.84
1.31
3.3
3.7
estimate
0.0
0.0
0.00
56
480
(3026493) Urate [Moles/volume] in Serum or Plasma
129
1517
0.81
1.30
2.9
2.8
umol/l
10448.8
6842.8
0.26
107
1306
(3031040) Bacteria [#/volume] in Urine by Automated count
382
3551
1.18
1.30
4.2
4.5
e6/l
3020.8
1569.2
—
5
62
(3005322) IgE [Units/volume] in Serum or Plasma
19
303
0.62
1.28
1.1
1.3
u/ml
350.4
197.0
0.36
19
274
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
85
1.78
1.24
1.5
1.6
—
—
—
0
0
(3000492) Spirometry study
66
516
1.31
1.23
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
116
1.66
1.22
3.7
3.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
287
0.62
1.22
2.6
3.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
310
0.63
1.20
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
508
5287
0.83
1.20
4.3
4.8
mmol/l
6.0
6.1
0.96
457
4794
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
37
265
1.42
1.19
1.9
1.9
ug/l
1.7
2.5
0.27
32
233
(44813793)
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
94
776
1.25
1.15
1.5
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
342
0.66
1.15
2.1
2.5
—
15.6
—
0
18
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
36
0.00
1.14
0.0
7.4
—
84.5
—
0
12
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
143
1.56
1.12
1.6
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
81
1.74
1.09
1.5
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
21
2.39
1.09
2.6
5.0
—
—
—
0
0
(3035880) pH of Pleural fluid
7
32
2.20
1.08
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
52
1.94
1.06
1.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
150
0.53
1.04
1.1
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
16
98
1.65
1.04
4.0
3.9
%
0.7
1.3
0.63
11
83
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
78
639
1.25
1.04
3.7
4.5
ug/l
5.0
31.1
1.33
71
543
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
253
2308
1.16
1.03
2.1
2.0
pmol/l
95.3
94.2
0.14
130
1208
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
68
1.78
1.01
5.1
4.0
—
—
—
0
0
(4268621)
9
48
1.89
1.00
1.9
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
132
1.53
0.98
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.1
—
7.2
—
0
8
(3035320) C reactive protein [Mass/volume] in Body fluid
7
36
1.95
0.97
1.4
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
31
0.00
0.96
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
493
5115
0.86
0.95
5.5
6.1
mmol/mol
38.8
40.4
4.16
454
4741
(3042631) Mycobacterium sp identified in Specimen
14
85
1.66
0.95
2.0
2.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
145
0.55
0.94
3.0
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
27
2.23
0.93
1.2
11.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.2
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.2
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.2
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
236
1.37
0.91
1.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
29
2.08
0.89
1.3
1.1
nmol/l
114.7
148.9
—
6
29
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
235
2553
0.88
0.88
4.3
4.9
ug/l
2.1
2.4
0.55
208
2298
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
135
1188
1.17
0.88
1.5
1.7
mg/l
1.5
1.3
0.52
101
930
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
30
2.01
0.87
1.5
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
30
2.01
0.87
1.5
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
126
1429
0.85
0.86
3.7
4.0
estimate
0.0
0.0
0.50
53
478
(3002179) Metamyelocytes/100 leukocytes in Blood
54
435
1.26
0.85
4.4
4.2
%
0.8
0.5
0.82
16
115
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
166
0.60
0.84
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
352
0.73
0.83
2.3
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
165
0.60
0.82
1.1
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
33
1.83
0.79
1.3
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(4027681)
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
65
541
1.22
0.78
1.3
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
56
459
1.24
0.78
4.4
4.4
%
0.1
0.2
0.24
19
146
(1761482) Bacteria [#/volume] in Urine by Culture
10
162
0.61
0.77
3.4
5.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
68
570
1.22
0.77
1.4
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
107
1.51
0.76
1.1
1.4
—
—
—
0
0
(1002224) Polysomnography panel
14
209
0.66
0.76
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
1.2
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
24
2.09
0.74
2.0
3.7
u/l
172.2
203.3
—
5
24
(3024928) Oxygen saturation in Venous blood
19
133
1.44
0.74
1.4
3.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
133
1.44
0.74
1.2
1.2
—
—
—
0
0
(4062490)
9
55
1.65
0.73
1.0
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
601
5894
1.22
0.73
34.5
22.8
e9/l
254.7
242.6
4.07
593
5734
(3024731) MCV [Entitic volume]
601
5895
1.21
0.73
34.4
22.7
fl
92.3
91.4
4.87
596
5799
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
92
1.53
0.72
1.5
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
601
5896
1.21
0.72
34.4
22.7
pg
30.7
30.5
2.89
596
5799
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
177
1.37
0.71
1.4
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
90
1032
0.85
0.71
1.3
1.2
u/ml
1.6
1.3
0.19
26
281
(3026361) Erythrocytes [#/volume] in Blood
601
5897
1.21
0.71
34.5
22.8
e12/l
4.2
4.5
30.00
591
5719
(3010813) Leukocytes [#/volume] in Blood
601
5897
1.21
0.71
34.5
22.8
e9/l
6.9
6.8
0.39
592
5720
(3025159) Blasts/100 leukocytes in Blood
52
428
1.23
0.71
4.7
4.4
%
0.1
0.1
0.22
17
121
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
143
1.41
0.71
1.6
1.7
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
26
1.93
0.70
1.0
2.2
%
93.8
103.9
—
5
26
(3023419) Bacteria identified in Sputum by Culture
14
93
1.52
0.70
2.1
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
169
0.64
0.70
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
169
0.64
0.70
3.2
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
77
1.57
0.69
1.6
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
238
0.71
0.68
1.6
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
167
0.65
0.66
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
58
686
0.83
0.66
1.3
1.3
titre
682.5
455.9
0.33
16
151
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
259
0.73
0.66
1.6
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
78
1.55
0.66
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
78
1.55
0.66
1.6
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
103
1.47
0.65
1.1
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
22
292
0.74
0.65
3.6
3.3
mmol/l
27.5
25.0
2.16
22
285
(3017446) Testosterone [Moles/volume] in Serum or Plasma
43
523
0.81
0.65
2.3
2.3
nmol/l
11.6
13.2
0.68
36
463
(3023520) Reticulocytes [#/volume] in Blood
62
526
1.20
0.64
1.8
2.8
e9/l
65.1
70.9
0.67
49
417
(3049717) Cytology report of Urine Cyto stain
21
280
0.74
0.64
2.5
2.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
79
1.53
0.63
1.6
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
79
1.53
0.63
1.6
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
79
1.53
0.63
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
121
1.42
0.63
1.4
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
241
2254
1.11
0.62
3.7
3.8
ng/l
36.5
55.6
0.64
188
1682
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
79
689
1.17
0.60
8.1
7.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
52
1.54
0.59
1.0
1.1
%
102.9
96.9
—
8
47
(40761535) Cells panel - Urine sediment
39
473
0.81
0.58
3.2
3.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
23
0.00
0.58
0.0
1.2
—
7.1
—
0
23
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
36
1.67
0.57
1.5
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
57
487
1.19
0.56
4.4
4.3
%
1.1
0.9
0.36
20
160
(4281824)
8
55
1.46
0.56
1.4
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
716
0.85
0.56
4.2
4.7
%
34.8
31.4
1.56
46
481
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
107
1.41
0.55
1.5
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
385
3700
1.10
0.55
3.9
4.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
295
0.77
0.55
1.5
1.7
—
—
—
0
0
(3013512) EKG study
185
1719
1.11
0.54
4.0
4.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
48
564
0.84
0.53
2.5
2.3
ug/g
303.8
141.8
0.55
39
460
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
62
1.46
0.53
2.0
2.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
43
360
1.21
0.53
3.4
2.8
e9/l
3.7
4.1
0.61
31
277
(3021879) Hepatitis B virus core Ab [Presence] in Serum
41
342
1.21
0.52
1.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
86
962
0.88
0.51
1.5
1.4
g/l
3.0
2.6
0.56
51
589
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
144
1.33
0.51
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
65
1.39
0.50
3.2
3.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
63
549
1.16
0.50
3.7
3.7
mmol/l
4.0
2.0
2.76
52
436
(40760888) Immunoglobulin light chains.free panel - Serum
20
155
1.30
0.47
3.0
4.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
353
0.81
0.47
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
48
1.46
0.47
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
489
4770
1.10
0.47
25.8
16.6
%
38.4
40.1
5.87
370
3269
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
81
0.61
0.46
3.2
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
74
659
1.14
0.45
1.4
1.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
50
1.40
0.45
1.0
1.0
mg/l
298.7
283.2
—
7
44
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
86
1.40
0.44
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
35
415
0.83
0.44
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
69
1.46
0.44
1.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
51
1.38
0.44
2.0
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
139
1.30
0.44
1.6
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
32
1.57
0.42
1.8
1.2
u/l
16.8
13.5
—
5
26
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.6
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.6
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
0.7
—
0
9
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(4198724)
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
0.4
—
0
10
(3042733) HLA Ab [Presence] in Serum
0
17
0.00
0.40
0.0
5.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
141
1.28
0.40
1.0
1.7
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
5
34
1.47
0.40
1.8
1.2
u/l
106.2
77.2
—
5
29
(3029075) Extractable nuclear Ab panel - Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
102
0.68
0.40
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
61
1.32
0.39
1.3
1.3
nmol/l
—
—
—
0
0
(4306422)
10
71
1.41
0.39
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
19
0.00
0.39
0.0
1.6
—
65.8
—
0
19
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
19
0.00
0.39
0.0
1.4
—
9.1
—
0
19
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.6
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
111
0.72
0.37
1.1
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
78
0.64
0.36
5.0
2.9
u/ml
17.2
27.4
—
5
78
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
140
1492
0.92
0.35
2.7
3.0
ug/l
0.8
0.7
0.48
93
1003
(40761536) Microorganisms panel - Urine sediment
51
452
1.14
0.35
3.5
3.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
154
1.24
0.34
1.6
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
87
0.69
0.33
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
231
0.82
0.33
1.3
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
90
0.66
0.33
1.5
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
53
1.32
0.31
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
53
1.32
0.31
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
53
1.32
0.31
1.1
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
61
554
1.11
0.30
2.2
2.5
ug/l
6.0
7.6
0.45
52
491
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
106
0.75
0.29
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
57
1.23
0.29
1.4
1.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
57
1.23
0.29
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
237
0.84
0.28
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
64
1.25
0.27
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
404
0.88
0.26
1.9
1.8
—
—
—
0
0
(4146454)
5
71
0.70
0.26
4.4
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
72
0.69
0.26
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
73
0.68
0.26
1.4
1.3
pmol/l
376.4
326.2
—
5
59
(3045142) Bone marrow Pathology biopsy report
9
72
1.25
0.25
1.4
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
105
1.24
0.25
1.1
1.2
—
—
—
0
0
(4094501)
12
148
0.81
0.24
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
87
1.27
0.24
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
169
0.82
0.24
1.9
2.5
ug/min
38.5
102.0
—
9
101
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
84
0.71
0.24
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
106
1.23
0.23
1.2
1.8
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
91
0.77
0.22
1.0
1.1
g/l
1.5
1.6
—
7
82
(3014271) Vancomycin [Susceptibility]
5
42
1.19
0.21
3.4
2.4
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.5
—
37.5
—
0
6
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
11
0.00
0.21
0.0
1.5
—
8.2
—
0
6
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
1.8
—
0
10
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
25.3
—
0
10
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
10
0.00
0.21
0.0
1.7
—
1.3
—
0
10
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
4.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
154
1.17
0.21
1.4
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
3.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
15.7
—
0
12
(3026008) Bacteria identified in Urine by Culture
167
1607
1.05
0.21
2.7
3.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
89
1.24
0.21
1.2
2.1
pg
31.8
33.2
0.39
11
89
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
2.4
—
0
6
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
111
0.81
0.20
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
111
0.81
0.20
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
32
289
1.11
0.19
1.3
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
363
0.90
0.18
4.2
3.8
mmol/l
2.6
1.7
0.65
27
276
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
175
1.15
0.18
1.5
1.5
ug/g
286.6
275.5
0.09
12
101
(3044290) Cell count panel - Cerebral spinal fluid
12
100
1.20
0.18
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
216
0.88
0.18
2.3
3.5
g/l
0.2
0.2
0.22
12
92
(3002523) Influenza virus A Ag [Presence] in Specimen
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
120
0.83
0.16
1.9
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
20
179
1.12
0.14
1.3
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
98
0.81
0.13
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
284
0.91
0.13
4.4
3.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
232
0.90
0.13
1.9
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
109
0.82
0.13
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
110
0.82
0.13
1.1
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
104
1.16
0.12
3.5
2.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
85
1.18
0.12
1.4
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
123
1194
1.04
0.11
1.6
1.7
pmol/l
92857621.0
4082063.0
0.47
98
980
(40760892) CBC W Ordered Manual Differential panel - Blood
118
1145
1.04
0.11
3.9
4.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
49
515
0.95
0.10
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
232
1.08
0.10
2.8
2.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
45
428
1.06
0.09
2.8
3.9
ng/l
69.2
87.6
1.08
40
378
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
281
1.07
0.09
2.2
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
62
645
0.96
0.09
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
175
1.09
0.08
1.5
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.1
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
65
1.08
0.08
1.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
403
1.05
0.07
2.1
2.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
18
167
1.08
0.07
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
92
0.87
0.06
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
94
0.85
0.06
2.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
99
1.11
0.06
7.4
3.4
—
—
—
0
0
(3009343) pH of Capillary blood
37
386
0.96
0.06
4.1
3.7
ph
7.4
7.4
—
5
50
(3016879) Cocaine [Presence] in Urine
9
102
0.88
0.06
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
103
0.87
0.06
1.3
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
129
1.09
0.05
2.4
2.3
g/l
122.9
129.3
—
9
97
(4034850)
18
169
1.07
0.05
15.4
11.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
19
200
0.95
0.04
1.6
1.8
nmol/l
39.9
40.7
0.05
19
189
(3011397) Hemoglobin [Presence] in Urine by Test strip
118
1195
0.98
0.03
2.9
3.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
320
1.03
0.03
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
102
1.08
0.03
1.1
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
38
372
1.02
0.01
2.6
3.3
g/l
119.1
127.1
1.03
38
367
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
126
1.03
0.00
2.8
3.8
mg/l
27.5
26.0
—
7
79
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
14
144
0.97
0.00
1.7
1.9
pmol/l
212.1
216.3
0.08
14
134
(3039443) Prostate specific Ag panel - Serum or Plasma
16
157
1.02
0.00
1.5
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
27
267
1.01
0.00
1.4
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
151
0.99
0.00
1.3
2.1
mg/l
9.5
12.2
1.21
15
138
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
21
209
1.00
0.00
3.4
3.1
u/ml
28.2
55.7
0.79
21
202
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
67
0.89
0.00
1.3
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
9
0.00
0.00
0.0
5.9
—
6.8
—
0
9
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
68
0.88
0.00
3.7
2.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
1.1
1.8
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
59
0.85
0.00
6.2
2.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
1.9
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
3.6
—
0.6
—
0
7
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
103.3
—
0
8
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
68
0.88
0.00
1.3
1.3
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
78
0.90
0.00
1.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
80
1.00
0.00
1.1
1.9
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
53
0.94
0.00
1.2
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.8
1.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
13.0
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TONGUE – Malignant neoplasm of tongue
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).